{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:53Z","timestamp":1786993553196,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1149990"],"award-info":[{"award-number":["1149990"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1135851"],"award-info":[{"award-number":["1135851"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HRP-12732"],"award-info":[{"award-number":["HRP-12732"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006348","name":"Delaney AIDS Research Enterprise","doi-asserted-by":"publisher","award":["1UM1AI164560\\u201301"],"award-info":[{"award-number":["1UM1AI164560\\u201301"]}],"id":[{"id":"10.13039\/100006348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023692","name":"Doherty Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032522","name":"Australian Red Cross","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032522","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jviromet.2025.115236","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:53:47Z","timestamp":1754434427000},"page":"115236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency"],"prefix":"10.1016","volume":"338","author":[{"given":"Kiho","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youry","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesslyn","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Tumpach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajantha","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah AD","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Hearps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-8241","authenticated-orcid":false,"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2025.115236_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00013-23","article-title":"Experimental models for HIV latency and molecular tools for reservoir quantification-an update","volume":"36","author":"Angamuthu","year":"2023","journal-title":"Clin. Microbiol Rev."},{"key":"10.1016\/j.jviromet.2025.115236_bib2","article-title":"Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice","volume":"4","author":"Arandjelovic","year":"2023","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.jviromet.2025.115236_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34655","article-title":"Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ t cells","volume":"7","author":"Battivelli","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.jviromet.2025.115236_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymthe.2006.02.010","article-title":"Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells","volume":"14","author":"Ben-Dor","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jviromet.2025.115236_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/viro.1997.8499","article-title":"Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations","volume":"230","author":"Bess","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2025.115236_bib6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat. Med"},{"key":"10.1016\/j.jviromet.2025.115236_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63810","article-title":"Infection with a newly designed dual fluorescent reporter HIV-1 effectively identifies latently infected CD4(+) t cells","volume":"10","author":"Cai","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jviromet.2025.115236_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2013.07.037","article-title":"Dual-color HIV reporters trace a population of latently infected cells and enable their purification","volume":"446","author":"Calvanese","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2025.115236_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004955","article-title":"HIV latency is established directly and early in both resting and activated primary CD4 t cells","volume":"11","author":"Chavez","year":"2015","journal-title":"Plos Pathog."},{"key":"10.1016\/j.jviromet.2025.115236_bib10","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jviromet.2025.115236_bib11","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1128\/JVI.03478-12","article-title":"A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection","volume":"87","author":"Dahabieh","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2025.115236_bib12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3389\/fimmu.2019.02251","article-title":"The quest for cellular markers of HIV reservoirs: any color you like","volume":"10","author":"Darcis","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jviromet.2025.115236_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 t cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"Doitsh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2025.115236_bib14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2025.115236_bib15","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1242\/jcs.115.13.2757","article-title":"Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8","volume":"115","author":"Fotin-Mleczek","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jviromet.2025.115236_bib16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/jvi.70.3.1651-1667.1996","article-title":"Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes a through G. The WHO and NIAID networks for HIV isolation and characterization","volume":"70","author":"Gao","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2025.115236_bib17","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1021\/jm401075x","article-title":"Discovery of a novel class of dimeric smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)","volume":"56","author":"Hennessy","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jviromet.2025.115236_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2025.115236_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks334","article-title":"A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA","volume":"40","author":"Hooker","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2025.115236_bib20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ t cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2025.115236_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/hum.2008.048","article-title":"Lentiviral vector design for optimal t cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes","volume":"20","author":"Jones","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jviromet.2025.115236_bib22","article-title":"Development of an HIV reporter virus that identifies latently infected CD4+ t cells","volume":"2","author":"Kim","year":"2022","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.jviromet.2025.115236_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25425","article-title":"Limitations of dual-fluorescent HIV reporter viruses in a model of pre-activation latency","volume":"22","author":"Kim","year":"2019","journal-title":"J. Int. Aids Soc."},{"key":"10.1016\/j.jviromet.2025.115236_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-1119(00)00334-6","article-title":"Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication","volume":"255","author":"Konopka","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.jviromet.2025.115236_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/QAI.0b013e31815dbf7f","article-title":"Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infection","volume":"47","author":"Lewin","year":"2008","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.jviromet.2025.115236_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb07020.x","article-title":"Mechanism of action of camptothecin","volume":"922","author":"Liu","year":"2000","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.jviromet.2025.115236_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12977-024-00639-w","article-title":"The cell biology of HIV-1 latency and rebound","volume":"21","author":"Mbonye","year":"2024","journal-title":"Retrovirology"},{"key":"10.1016\/j.jviromet.2025.115236_bib28","doi-asserted-by":"crossref","first-page":"26895","DOI":"10.18632\/oncotarget.4822","article-title":"A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer","volume":"6","author":"Moon","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jviromet.2025.115236_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-020-1951-3","article-title":"Systemic HIV and SIV latency reversal via non-canonical NF-kappaB signalling in vivo","volume":"578","author":"Nixon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2025.115236_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12915-022-01386-0","article-title":"Rapid increase in transferrin receptor recycling promotes adhesion during t cell activation","volume":"20","author":"Rossatti","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.jviromet.2025.115236_bib31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.immuni.2017.09.014","article-title":"Transcriptional reprogramming during Effector-to-Memory transition renders CD4(+) t cells permissive for latent HIV-1 infection","volume":"47","author":"Shan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jviromet.2025.115236_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jviromet.2025.115236_bib33","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.aaa7227","article-title":"GENE SILENCING. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells","volume":"348","author":"Tchasovnikarova","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2025.115236_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jviromet.2013.08.029","article-title":"A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ t cell subsets","volume":"195","author":"Tilton","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2025.115236_bib35","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093425001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093425001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:57:19Z","timestamp":1779681439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093425001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S0166093425001296"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2025.115236","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2025.115236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115236"}}